Bayesian reconstruction of rapidly scanned mid-infrared optoacoustic signals enables fast, label-free chemical microscopy
Berger C., Kim M., Scheel-Platz L., Eigenberger A., Prantl L., Liu P.
Laboratory Study, published in Sci Adv (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Sci Adv (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40845115
- PMCID
- PMC12372899
- DOI
- 10.1126/sciadv.adu7319
- Citations
- 3
Abstract (original English)
Hyperspectral optoacoustic microscopy (OAM) enables obtaining images with label-free biomolecular contrast, offering excellent perspectives as a diagnostic tool to assess freshly excised and unprocessed biological samples. However, time-consuming raster scanning image formation currently limits the translation potential of OAM into the clinical setting, for instance, in intraoperative histopathological assessments, where micrographs of excised tissue need to be taken within a few minutes for fast clinical decision-making. Here, we present a non-data-driven computational framework tailored to enable fast OAM by rapid data acquisition and model-based image reconstruction, termed Bayesian raster-computed optoacoustic microscopy (BayROM). Unlike data-driven approaches, BayROM does not require training datasets, but instead, it uses probabilistic model-based reconstruction to facilitate fast high-resolution imaging. We show that BayROM enables acquiring micrographs 10 times faster on average than conventional raster scanning microscopy and provides sufficient image quality to facilitate the intraoperative histological assessment of processed fat grafts for autologous fat transfer.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.